CUTANEOUS MASTOCYTOSIS AND DRUG ALLERGY
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Mastocytosis is a clinically and biologically heterogeneous group of disorders characterized by clonal proliferation and accumulation of mast cells in the skin and/or systemic organs. Cutaneous masto-cytosis is the most common form observed during childhood and is typically confined to the skin. It generally follows a benign clinical course with a tendency toward spontaneous regression. Neverthe-less, even in cutaneous mastocytosis, symptoms related to the release of mast cell mediators may lead to clinically significant morbidity. In particular, reactions occurring after drug exposure represent a source of considerable concern for patients and their families, as well as for clinicians. Mast cells play a central role in the regulation of vascular permeability, smooth muscle contraction, and inflammatory responses through the release of numerous biologically active mediators, including histamine, tryptase, prostaglandins, leukotrienes, and cytokines. In patients with mastocytosis, drug-induced hypersensi-tivity reactions frequently arise as a result of activation of receptors expressed on the mast cell surface or through direct activation of the cell membrane. Key mast cell receptors implicated in these reac-tions include the stem cell factor receptor (c-KIT), immunoglobulin receptors (FcRI and FcRI), the Mas-related G protein–coupled receptor X2 (MRGPRX2), and complement receptors such as C5aR (CD88). A substantial proportion of the reactions observed in these patients are associated with IgE-in-dependent mast cell activation, rather than with classical IgE-mediated immunological drug allergy. In cutaneous mastocytosis, the main drug categories reported to be associated with adverse reactions include nonsteroidal anti-inflammatory drugs (NSAIDs), opiates and opioid derivatives, radiocontrast agents, certain anesthetic agents, antibiotics, and vaccines. Available evidence from the literature indi-cates that routine drug restriction is not warranted in patients without a previously documented history of drug-related reactions. Failure to accurately distinguish between true drug allergy and pseudoaller-gic reactions secondary to mast cell activation may result in unnecessary drug avoidance, limitation of therapeutic options, and uncertainty in clinical management. Therefore, in patients with cutaneous mastocytosis, a thorough understanding of the mechanisms underlying drug-related reactions, appro-priate positioning of drug allergy in the differential diagnosis, and the adoption of evidence-based clin-ical approaches are of paramount importance. In this section, the underlying mechanisms of drug-as-sociated reactions in cutaneous mastocytosis, the role of drug allergy in the differential diagnosis, and current clinical management strategies are reviewed in the light of the existing literature. Keywords: Drug hypersensitivity; Mast cell activation disorders; Anaphylaxis; Cutaneous mastocytosis; Non-steroidal anti-inflammatory agents
Fields of Study & Subjects
Mast cells and histamine
Drug-Induced Adverse Reactions
Food Allergy and Anaphylaxis Research
Publication details
- Journal / source
- Turkiye Klinikleri eBooks
- Pages
- 105–113
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Book chapter